Michael Kattah, MD, PhD
Studies
- Growing intestinal organoids (mini-guts) from patients
- Studying how IBD-associated genes affect the cells that line the gut
- Using”multi-omics” single-cell approaches to identify signatures associated with disease and treatment response in IBD patients
Publications
- Kattah MG, Shao L, et al. A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival. J Exp Med. 2018
- Kattah MG, Milush JM, et al, Mahadevan U. Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Clin Transl Gastroenterol. 2018
- Kattah MG, Malynn BA, Ma A. Ubiquitin-Modifying Enzymes and Regulation of the Inflammasome. J Mol Biol. 2017
Interests
- Single-cell analysis and “multi-omics” approaches
- Precision medicine (identifying the best treatment for each patient)
- Supporting the transition of young adults from pediatric to adult GI clinic
- Colitis associated with cancer immunotherapy
Awards
- Burroughs Wellcome Fund Career Award for Medical Scientists
- ImmunoX CoProject Pilot Award
- Recognition for Scientific Accomplishment as an Early-Stage Investigator DDW